Riskpilot← Back to searchSign inGet full accessTunstall Health A/S
A/SDissolvedCVR 30514343Niels Bohrs Vej 42Engroshandel med telekommunikationsudstyr · NACE 465220Est. 20082 employees
Revenue 2021
DKK 71K
-99% vs 2020
EBITDA margin
66.2%
-99% vs 2020
Equity ratio
-78.0%
Financial strength
Net profit 2021
DKK -588K
-124% vs 2020
| Revenue | DKK 71K | -99% |
| EBITDA | DKK 47K | -99% |
| Net profit | DKK -588K | -124% |
| Total assets | DKK 3,5M | -11% |
| Equity | DKK -2,7M | -27% |
| Employees | 2 | — |
Legal name
Tunstall Health A/S
CVR number
30514343
Legal form
Aktieselskab
NACE code
465220 · Engroshandel med telekommunikationsudstyr
Founded
19. september 2008
Share capital
DKK 2.500.000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2021-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af 1 direktør i forening med 1 bestyrelsesmedlem, 2 bestyrelsesmedlemmer, eller af den samlede bestyrelse i forening.
Address
Niels Bohrs Vej 42
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | -4.393 | -4.209 | 2.767 | 6.879 | 71 |
| Staff expenses | -5.001 | -4.146 | -6.955 | -2.911 | -24 |
| EBITDA | -7.767 | -8.355 | -4.188 | 3.968 | 47 |
| Depreciation & amort. | -3.072 | -355 | -899 | -763 | -464 |
| EBIT | -10.839 | -8.710 | -5.087 | 3.205 | -417 |
| Net financials | -25 | -22 | -265 | -790 | -373 |
| Profit before tax | -10.864 | -8.732 | -5.352 | 2.415 | -790 |
| Tax | -2.389 | -1.011 | -1.143 | -0 | -202 |
| Net profit | -8.475 | -7.721 | -4.209 | 2.415 | -588 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 4.784 | 2.908 | 5.710 | 3.936 | 3.496 |
| Equity | 1.003 | -344 | -4.554 | -2.139 | -2.727 |
| Long-term debt | 1.344 | 0 | 0 | 0 | 0 |
| Short-term debt | 3.781 | 3.252 | 10.264 | 6.075 | 6.223 |
| Total debt | 3.781 | 3.252 | 10.264 | 6.075 | 6.223 |
EBITDA margin
66.2%
This company
15.8%
Market median
+319% vs market
20172021
Equity ratio
-78.0%
This company
38.2%
Market median
-304% vs market
20172021
Return on equity
-58800000.0%
This company
18.4%
Market median
-319565317% vs market
20172021
Net profit margin
-828.2%
This company
8.1%
Market median
-10325% vs market
20172021
Asset turnover
0.02×
This company
1.12×
Market median
-98% vs market
20172021
Debt / equity
2.28×
This company
0.62×
Market median
-268% vs market
20172021
- Annual report 2021Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via CVR / Virk · Period 2019-10-01 – 2020-09-30
- Annual report 2019Filed via CVR / Virk · Period 2018-10-01 – 2019-09-30
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-09-30
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
| Name | Role | Member since |
|---|---|---|
| Former (4) | ||
KC Management | Management | 2008 – 2016 |
MW Chief Executive Officer | Chief Executive Officer | 2018 – 2022 |
JL Chief Executive Officer | Chief Executive Officer | 2022 – 2023 |
BD Management | Management | 2016 – 2018 |
| Name | Role | Member since |
|---|---|---|
| Former (15) | ||
| Chairman | 2018 – 2018 | |
| Chairman | 2018 – 2022 | |
| Board of Directors | 2008 – 2011 | |
| Board of Directors | 2008 – 2014 | |
| Chairman | 2018 – 2018 | |
| Board of Directors | 2008 – 2011 | |
| Deputy Chairman | 2018 – 2018 | |
| Chairman | 2018 – 2018 | |
| Deputy Chairman | 2017 – 2018 | |
| Chairman | 2022 – 2023 | |
| Chairman | 2011 – 2014 | |
| Board of Directors | 2022 – 2023 | |
| Board of Directors | 2019 – 2022 | |
| Chairman | 2014 – 2017 | |
| Board of Directors | 2018 – 2019 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2016 | |
| Individual | 100% | 100% | 2018 | |
| Company | 100% | 100% | 2018 | |
| Company | 10–14.99% | 10–14.99% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Tunstall Health A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kurt Christensen | Management | 0 companies |
| Mads Wojtynka | Chief Executive Officer | 0 companies |
| Jan Lochmann | Chief Executive Officer | 0 companies |
| Bettina Drefeld Eriksen | Management | 0 companies |
| Lars Bonderup Bjørn | Chairman | 0 companies |
| Kristoffer Birger Viktor Axelsson | Chairman | 0 companies |
| Mette Danielsen | Board of Directors | 0 companies |
| Claus Tolgaard | Board of Directors | 0 companies |
| Jens Christian Sørensen | Chairman | 0 companies |
| Jette Nellemose Tolgaard | Board of Directors | 0 companies |
| Pernille Iversen | Deputy Chairman | 0 companies |
| Nina Bruun | Chairman | 0 companies |
| Henrik Ejsing Andreasen | Deputy Chairman | 0 companies |
| Emil Edward Peters | Chairman | 0 companies |
| Jørn Kildegaard Andersen | Chairman | 0 companies |
| Jesper Bjerregaard Christensen | Board of Directors | 0 companies |
| Lars Alf Thomas Pehrsson | Board of Directors | 0 companies |
| Knud Bent Steen Larsen | Chairman | 0 companies |
| Lars Håkan Johansson | Board of Directors | 0 companies |